Modifiable and non-modifiable characteristics associated with sleep disturbance in oncology outpatients during chemotherapy.

ABSTRACT:

Purpose

In a sample of outpatients with breast, gastrointestinal, gynecological, and lung cancer who received at least two cycles of chemotherapy (CTX), the purposes were to evaluate for inter-individual differences in the severity of sleep disturbance and determine which demographic, clinical, and symptom characteristics were associated with initial levels as well as the trajectories of sleep disturbance.

Methods

A total of 1331 patients completed study questionnaires in their homes, at six time points over two cycles of CTX (prior to CTX administration, approximately 1 week after CTX administration, and approximately 2 weeks after CTX administration). Questionnaires included demographic, clinical, and symptom assessments (i.e., General Sleep Disturbance Scale, Lee Fatigue

SUBMITTER: Mark S 

PROVIDER: S-EPMC5481474 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature